Extracellular vesicles and mitochondria in central nervous system diseases
Extracellular vesicles (EVs) are naturally secreted as non-cell-autonomous signals involved in regulating immune responses, aging, angiogenesis, and tissue injury and repair within the central nervous system (CNS). Consequently, EVs have emerged as promising therapeutic targets in CNS-related diseases. More recently, a subset of these vesicles has been found to contain mitochondria (mitoEVs), suggesting that vesicles carrying mitochondrial signatures may also function as non-cell-autonomous signals and serve as potential biomarkers for injury or recovery in CNS pathophysiology. In this mini-review, we summarize current findings highlighting the critical roles of EVs and their therapeutic potential as demonstrated in cellular, animal, and human studies related to CNS injury and disease.
Authors
- Ji-Hyun Park (ORCID: https://orcid.org/0000-0002-4714-930X)
- Gen Hamanaka (ORCID: https://orcid.org/0000-0003-0957-2817)
- David Back (ORCID: https://orcid.org/0000-0002-7381-4799)
- Kazuhide Hayakawa (ORCID: https://orcid.org/0000-0002-1229-2413)
- Shin Ishikane (ORCID: https://orcid.org/0000-0002-1743-7730)
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Journal of Cerebral Blood Flow & Metabolism
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1177/0271678x251399018
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00